Table 3.
Checkpoint Blockade in CAR T Cells | Mechanism | Reference |
---|---|---|
Anti-checkpoint antibody secretion | Blockade of PD-L1 on tumour cells | Suarez et al143 |
Anti-checkpoint scFv secretion | Blockade of PD-L1 on tumour cells | Zhou et al144 Li et al145 Rafiq et al146 Ping et al147 |
Dominant negative receptor | Expression of PD-1 receptor lacking intracellular domain outcompetes binding to PD-L1 | Cherkassky et al148 |
Knockout of checkpoint receptors | Knock out of PD-1 by CRISPR/Cas9 | Ren et al149 Rupp et al150 Choi et al151 |
Checkpoint receptor downregulation | Incorporation of shRNAs/siRNAs in CAR T cells for downregulation of PD-1/Tim-3/Lag-3/CTLA-4 expression | Cherkassky et al148 Liu et al152 Zou et al153 Simon et al154 Condomines et al155 |
Secretion of minibodies | Blockade of CTLA-4 on tumours | Yin et al156 |
Switch receptors | Conversion of PD-1 inhibitory signal to costimulatory or activating signal as in PD-1/CD28 switch receptor or PD-1 CARs | Liu et al157 Liu et al158 Parriott et al159 |